BCBM results are concerning me as there doesn't appear to be anything at AACR.
I'm no expert on things medical, so I can see 2 options:
1) results are not worth publishing. James has mentioned that they did not expect all trials to be successful. I would have thought though that if this was the case then the researchers would put something out, or if they didn't want to publish (do they have to?) then they'd advise the company who would then release information to the market. As that has not (yet) happened, I'm hopeful that point 2 is what is happening
2) the results are really good and the criteria for interim reporting has not been met. However the trial information says a secondary outcome was clinical benefit at 18 and 24 weeks so I would have though that would be reported by now.
So I'd welcome anyone with any sort of knowledge on the reporting of clinical trials to put their thoughts out there.
KZA Price at posting:
$1.34 Sentiment: Buy Disclosure: Held
